APA (7th ed.) Citation

NM, M., A, D., N, M., KC, T., BW, H., K, M., . . . FY, B. (2026). Virtual Bioequivalence Assessment of Long-acting Injectable Suspensions Using PBPK Modeling: Part 1. Impact of particle Size on Formulation Variability. The AAPS journal, 28(3), . https://doi.org/10.1208/s12248-026-01213-2

Chicago Style (17th ed.) Citation

NM, Morris, et al. "Virtual Bioequivalence Assessment of Long-acting Injectable Suspensions Using PBPK Modeling: Part 1. Impact of Particle Size on Formulation Variability." The AAPS Journal 28, no. 3 (2026). https://doi.org/10.1208/s12248-026-01213-2.

MLA (9th ed.) Citation

NM, Morris, et al. "Virtual Bioequivalence Assessment of Long-acting Injectable Suspensions Using PBPK Modeling: Part 1. Impact of Particle Size on Formulation Variability." The AAPS Journal, vol. 28, no. 3, 2026, https://doi.org/10.1208/s12248-026-01213-2.